SOLICITATION NOTICE
Q -- Regent-Drop Shipment
- Notice Date
- 5/16/2011
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- Department of the Navy, Bureau of Medicine and Surgery, NH Okinawa, U. S. Naval Hospital Okinawa, PSC 482, Box 248, FPO, 96362-1695, United States
- ZIP Code
- 96362-1695
- Solicitation Number
- N6847012RQBL002
- Archive Date
- 6/17/2011
- Point of Contact
- Fumikazu Higa, Phone: 3156437290, Denzil D Lawrence, Phone: 11-81-611-743-7782
- E-Mail Address
-
fumikazu.higa@med.navy.mil, denzil.lawrence@med.navy.mil
(fumikazu.higa@med.navy.mil, denzil.lawrence@med.navy.mil)
- Small Business Set-Aside
- N/A
- Description
- This is a combined synopsis/solicitation prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. The request for quote number is N6847011RQBL005. The following provisions and clauses apply plus any addenda: FAR 52.212-1 Instructions to Offerors - Commercial Items; FAR 52.212-2 Evaluation - Commercial Items; FAR 52.212-3 Offeror Representations and Certifications --Commercial Items; and FAR 52.212-4 Contract Terms and Conditions - Commercial Items; FAR 52.212-5, Contract Terms and Conditions Required To Implement Statutes Or Executive Orders -- Commercial Items; additional FAR clauses cited in the clause are: 52.222-3, Convict Labor; 52.222-26, Equal Opportunity; 252.232-7003, Electronic Submission of Payment Requests and Receiving Reports, NAICS Code for this requirement is 325413. The intention is to award a Firm-Fixed Price contract. The U.S. Naval Hospital, Okinawa, Japan intends to negotiate a sole-source contract with AcroMetrix for the following items with two year options. 1.. VeriSure Pro Control HCV/HIV/NEG; # 96-3700; 9 BX Reagents MUST be delivered on OCTOBER,FEBRUARY,and JUNE the expiration date no less than 1 year. Three(3) per shipment 2. VeriSure Pro HBV Positive Control; # 96-3603; 27 BX Reagents MUST be delivered on OCTOBER,FEBRUARY,and JUNE the expiration date no less than 1 year. Nine(9) per shipment. 3. VeriSure Pro WNV Control (Positive & Negative); # 96-0700; 9 BX Reagents MUST be delivered on OCTOBER,FEBRUARY,and JUNE the expiration date no less than 1 year. Three(3) per shipment. However, any responsible source that can meet the requirements may submit the written notification to the Point of Contact (POC). Supporting documents must be furnished in sufficient detail, to demonstrate the offeror?fs capability to provide and ability to comply with the requirements. Offerors responding to this notice must be FDA approved for the manufacture, sale and distribution of these products. Offerors must be registered in Central Contractor Registration. [Note: Lack of registration in the Central Contractor Registration will make a Contractor ineligible for award] Registration is available via the Internet at www.ccr.gov. The place of delivery will be directly to U.S. Naval Hospital, Okinawa, Japan, BLDG. 6000, Camp Lester, Okinawa, Japan 904-0103, via Naha Airport. The Government will award a contract resulting from this solicitation to the responsible offeror whose quote conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate quotes: (1) Technical capability of the item quoted to meet the Government requirement (including submission of descriptive literature); (2) Price. Quotes must be submitted to the POC no later than Jun 2, 2010; 11AM; Japan standard time. (3) Past Performance. Quotes shall be submitted via e-mail in Word, Excel, or PDF format to the POC, Fumikazu Higa at fumikazu.higa@med.navy.mil or faxed to 011-81-98-893-5754. Responses received will be evaluated; however, a determination by the Government not to compete the proposed procurement based upon responses to this notice is solely within the discretion of the Government. If no responses are received, U.S. Naval Hospital, Okinawa, Japan will proceed with the sole source procurement. Contracting Office Address: U. S. Naval Hospital Okinawa, PSC 482, Box 248 FPO, 96362-1695 United States Place of Performance: US NAVY HOSPITAL OKINWA JAPAN BLDG 6000 CAMP LESTER AZA KUWAE, CHATAN-CHO NAKAGAMI-GUN OKINAWA JAPAN 904-0103 CHATAN CHO, Non-U.S. 9363 Japan Primary Point of Contact.: Fumikazu Higa, REAGENTS fumikazu.higa@med.navy.mil Phone: 3156437290 Secondary Point of Contact: Denzil D Lawrence, PURCHASING AGENT denzil.lawrence@med.navy.mil Phone: 11-81-611-743-7782 Fax: 011-81-98-892-4974
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/DON/BUMED/N68470/N6847012RQBL002/listing.html)
- Place of Performance
- Address: US NAVAL HOSPITAL OKINAWA JAPAN, BLDG 6000, CAMP LESTER, AZA KUWAE, CHATAN-CHO, NAKAGAMI-GUN, OKINAWA JAPAN 904-0103, Non-U.S., 904-0103, Japan
- Record
- SN02448317-W 20110518/110516234126-dbae09f751efa18261c08fa60792f874 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |